4-[(4-Chloro-3-methylphenoxy)methyl]benzohydrazide, 250mg

Objectif à immersion dans l'huile E-Plan phase EPLPH S100x/1,25. Distance de travail 0,19 mm

3-(1,3-benzothiazol-2-yl)-6-ethyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-amine, 95.0%, 500mg

(E)-3-(5-Nitrofuran-2-yl)acrylaldehyde, 98%, 100mg

ethyl 4,7-dichloro-8-methylquinoline-3-carboxylate, 95.0%, 5g

2-Chloro-5-fluoro-3-methoxypyridine, 95.0%, 1g

Methyl 6-chloro-5-methylpicolinate, 95.0%, 5g

(S)-2-((Tert-butoxycarbonyl)amino)-3-cyclobutylpropanoic acid, 98%, 100mg

tert-Butyl 7-bromo-5-oxa-2-azaspiro[3.4]octane-2-carboxylate, 95+%, 250mg

4-Amino-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidin-2(1H)-one, 95.0%, 25g

5-chloro-1,3-benzoxazol-2(3H)-one, 98.0%, 100g

Ethyl 2-[6-(formamidomethyl)-3-phenyl-2-pyridyl]acetate, 97%, 1g

1,3,4,6-Tetra-O-acetyl-2-deoxy-2-phthalimido-beta-D-glucopyranose>97.0%(HPLC)5g